BrightPath Biotherapeutics Co., Ltd.
TSE:4594.T
50 (JPY) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -1,168.082 | -1,483.733 | -1,481.772 | -1,717.214 | -1,859.861 | -1,880.529 | -1,573.292 | -1,116.928 | -992.977 | -408.432 |
| Depreciation & Amortization
| 0.395 | 16.719 | 35.123 | 66.688 | 62.471 | 82.77 | 73.21 | 42.707 | 19.304 | 8.802 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 46.075 | 241.123 | -3.046 | 17.551 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0.872 | 14.01 | 34.574 | 20.216 | 0 | 0 |
| Change In Working Capital
| 3.512 | 16.878 | -15.265 | -12.186 | -17.193 | 117.993 | -20.321 | 16.668 | 43.011 | -33.854 |
| Accounts Receivables
| 0.049 | 16.53 | -16.302 | 0.376 | 0.181 | 76.171 | -22.067 | 51.804 | -27.15 | 0 |
| Inventory
| 0 | -238.335 | 47.618 | 82.98 | 4.329 | 27.569 | 14.74 | -6.07 | 112.261 | -13.417 |
| Accounts Payables
| -0.056 | -1.835 | 1.444 | -0.346 | -27.519 | 19.564 | -13.785 | -41.142 | 8.388 | 0 |
| Other Working Capital
| 3.519 | 240.518 | -48.025 | -95.196 | 5.816 | -5.311 | -35.061 | 22.738 | -69.25 | -20.437 |
| Other Non Cash Items
| 8.052 | 245.735 | -50.108 | -107.136 | -16.825 | -32.938 | -102.461 | -47.726 | 21.951 | -13.713 |
| Operating Cash Flow
| -1,156.92 | -1,204.401 | -1,512.022 | -1,769.848 | -1,784.461 | -1,457.571 | -1,591.336 | -1,067.512 | -908.711 | -447.197 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -7.648 | -1.76 | -17.646 | -35.274 | -110.132 | -175.257 | -111.555 | -103.842 | -32.125 | -42.863 |
| Acquisitions Net
| 0 | 0 | 0.08 | 0 | 0.495 | -7.2 | 0 | 7.277 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.277 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | -0.937 | 2.758 | -2.658 | -0.001 | 0.001 | 0 | -23.991 |
| Investing Cash Flow
| -7.648 | -1.76 | -17.566 | -36.211 | -106.879 | -185.115 | -111.556 | -96.564 | -32.125 | -66.854 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -112.5 | -87.5 | -212.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 573.382 | 519.604 | 478.051 | 2,052.505 | 10.75 | 15.81 | 3,268.908 | 3,514.088 | 2,672.558 | 1,247.716 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -2.228 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.076 | 0 | 303.675 | 0.585 | -0.001 | 0 | 12.174 | 45.1 | 0 | 0 |
| Financing Cash Flow
| 690.959 | 432.104 | 569.226 | 2,053.09 | 8.521 | 15.81 | 3,281.082 | 3,559.188 | 2,672.558 | 1,247.716 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.001 | -0.002 | 0 | -0.001 | 0 | -0.001 | -0.001 |
| Net Change In Cash
| -473.609 | -774.057 | -960.362 | 247.032 | -1,882.821 | -1,626.876 | 1,578.189 | 2,395.112 | 1,731.721 | 733.664 |
| Cash At End Of Period
| 1,057.36 | 1,530.969 | 2,305.026 | 3,265.388 | 3,018.356 | 4,901.177 | 6,528.759 | 4,950.57 | 2,555.458 | 823.737 |